Suppr超能文献

通过多种类拟天然产物的合成及环扭曲作用鉴定用于抑制甾醇转运蛋白的优势骨架。

Identification of a Privileged Scaffold for Inhibition of Sterol Transport Proteins through the Synthesis and Ring Distortion of Diverse, Pseudo-Natural Products.

作者信息

Bro Frederik Simonsen, Depta Laura, Dekker Nienke J, Bryce-Rogers Hogan P, Madsen Maria Lillevang, Præstegaard Kaia Fiil, Petersson Tino, Whitmarsh-Everiss Thomas, Kubus Mariusz, Laraia Luca

机构信息

Department of Chemistry, Technical University of Denmark, 2800, Kongens Lyngby, Denmark.

出版信息

ACS Cent Sci. 2025 Jan 9;11(1):136-146. doi: 10.1021/acscentsci.4c01657. eCollection 2025 Jan 22.

Abstract

Sterol transport proteins mediate intracellular sterol transport, organelle contact sites, and lipid metabolism. Despite their importance, the similarities in their sterol-binding domains have made the identification of selective modulators difficult. Herein we report a combination of different compound library synthesis strategies to prepare a cholic acid-inspired compound collection for the identification of potent and selective inhibitors of sterol transport proteins. The fusion of a primary sterol scaffold with a range of different fragments found in natural products followed by various ring distortions allowed the synthesis of diverse sterol-inspired compounds. This led to the identification of a complex and three-dimensional spirooxepinoindole as a privileged scaffold for sterol transport proteins. With careful optimization of the scaffold, the selectivity could be directed toward a single transporter, as showcased by the development of a potent and selective Aster-A inhibitor. We suggest that the combination of different design strategies is generally applicable for the identification of potent and selective bioactive compounds with drug-like properties.

摘要

甾醇转运蛋白介导细胞内甾醇转运、细胞器接触位点和脂质代谢。尽管它们很重要,但它们甾醇结合域的相似性使得鉴定选择性调节剂变得困难。在此,我们报告了不同化合物库合成策略的组合,以制备一种受胆酸启发的化合物集合,用于鉴定甾醇转运蛋白的强效和选择性抑制剂。将初级甾醇支架与天然产物中发现的一系列不同片段融合,然后进行各种环扭曲,从而合成了多种受甾醇启发的化合物。这导致鉴定出一种复杂的三维螺环氧杂氮杂吲哚作为甾醇转运蛋白的优势支架。通过对支架的仔细优化,可以将选择性导向单个转运蛋白,一种强效且选择性的Aster-A抑制剂的开发就证明了这一点。我们认为,不同设计策略的组合通常适用于鉴定具有类药物性质的强效和选择性生物活性化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b4/11758220/da3ac29f5afd/oc4c01657_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验